You may have heard about the recent acquisition of Ann Arbor’s gene therapy solutions company, RetroSenseTherapeutics. Sean Ainsworth, founder and CEO of RetroSense, sits down with Ann Arbor SPARK’s CEO, Paul Krutko, to discuss the technology behind the company – Optogenetics – the company’s acquisition by Allergen, Sean’s background and what led him to start RetroSense, and how this solution benefits the average person. RetroSense was recently named Entrepreneurial Company of the Year at Ann Arbor SPARK’s Annual Meeting. You can see the award video here.
Listen to the podcast on SoundCloud
Subscribe to our newsletters
Don’t miss an event, announcement, or job opportunity. Get news delivered to your inbox and stay informed about what is going on in tech, business, and talent in the greater Ann Arbor region.